Abstract
Single nucleotide polymorphisms (SNPs) are the most frequent variants in many genes and are promising markers in relation to drug responses in pharmacogenomics studies. In this review, we emphasized the importance of the cheminformatic-related and SNPrelated resources and tools and how they can improve pharmacogenomics studies. Currently, many cheminformatic resources are well developed and provide much information on drug metabolism and targeting. In parallel, there are also many well established SNP-related resources that are able to provide the information related to SNP genotyping, tag SNPs and functional classification. However, cheminformatic and SNP resources have not, as yet, been well-integrated to provide a user-friendly platform for pharmacogenomics studies. This paper presents a brief overview of the many available public resources for cheminformatics (DrugBank, PharmGKB and other drugrelated databases) and SNPs (dbSNP, HapMap, SNP500Cancer, SNP-RFLPing 2 and other SNP tools) and points out the importance of integrating cheminformatic and SNP resources for the future of pharmacogenomics.
Keywords: Pharmacogenomics, cheminformatics, SNP, genotyping, RFLP, drug, protein interaction.
Current Drug Metabolism
Title:The Importance of Integrating SNP and Cheminformatics Resources to Pharmacogenomics
Volume: 13 Issue: 7
Author(s): Hsueh-Wei Chang, Li-Yeh Chuang, Ming-Tz Tsai and Cheng-Hong Yang
Affiliation:
Keywords: Pharmacogenomics, cheminformatics, SNP, genotyping, RFLP, drug, protein interaction.
Abstract: Single nucleotide polymorphisms (SNPs) are the most frequent variants in many genes and are promising markers in relation to drug responses in pharmacogenomics studies. In this review, we emphasized the importance of the cheminformatic-related and SNPrelated resources and tools and how they can improve pharmacogenomics studies. Currently, many cheminformatic resources are well developed and provide much information on drug metabolism and targeting. In parallel, there are also many well established SNP-related resources that are able to provide the information related to SNP genotyping, tag SNPs and functional classification. However, cheminformatic and SNP resources have not, as yet, been well-integrated to provide a user-friendly platform for pharmacogenomics studies. This paper presents a brief overview of the many available public resources for cheminformatics (DrugBank, PharmGKB and other drugrelated databases) and SNPs (dbSNP, HapMap, SNP500Cancer, SNP-RFLPing 2 and other SNP tools) and points out the importance of integrating cheminformatic and SNP resources for the future of pharmacogenomics.
Export Options
About this article
Cite this article as:
Chang Hsueh-Wei, Chuang Li-Yeh, Tsai Ming-Tz and Yang Cheng-Hong, The Importance of Integrating SNP and Cheminformatics Resources to Pharmacogenomics, Current Drug Metabolism 2012; 13 (7) . https://dx.doi.org/10.2174/138920012802138679
DOI https://dx.doi.org/10.2174/138920012802138679 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Severe Acute Respiratory Syndrome (SARS): A Brief Review With Exploration of the Outcomes, Prognostic Factors and Sequelae
Current Respiratory Medicine Reviews Conjugation of Resveratrol with RGD and KGD Derivatives
Protein & Peptide Letters Evaluation of Clinical Efficacy of Fasudil for the Treatment of Pulmonary Arterial Hypertension
Recent Patents on Cardiovascular Drug Discovery Biologic Therapies in Primary Sjögren's Syndrome
Current Pharmaceutical Biotechnology Arterial Stiffness and Cardiovascular Drugs
Current Pharmaceutical Design Functional Recovery After Stroke: A Review of Current Developments in Stroke Rehabilitation Research
Reviews on Recent Clinical Trials A1 Receptors Ligands: Past, Present and Future Trends
Current Topics in Medicinal Chemistry Percutaneous Treatment of Aortic Valve Disease: Contemporary Overview and Future Trends
Current Pharmaceutical Design Early Vascular Ageing (EVA): Definitions and Clinical Applicability
Current Hypertension Reviews Sleep Related Disorders in the Elderly: An Overview
Current Respiratory Medicine Reviews Cardiac SPECT-CT and PET-CT Imaging
Current Medical Imaging Long-term Outcomes of Mitral Valve Repair Versus Replacement for Degenerative Disease: A Systematic Review
Current Cardiology Reviews Insulin Resistance and Postprandial Hyperglycemia the Bad Companions in Natural History of Diabetes: Effects on Health of Vascular Tree
Current Diabetes Reviews Large Artery Stiffness and Antihypertensive Agents
Current Pharmaceutical Design Critical Roles of Insulin-Induced Senescence in Diabetic Vasculopathy
Vascular Disease Prevention (Discontinued) von Willebrand Factor, von Willebrand Factor-Cleaving Protease, and Shear Stress
Cardiovascular & Hematological Agents in Medicinal Chemistry Adiponectin - A Novel Anti-Atherogenic Factor in the Metabolic Syndrome: Mechanisms of Action and Therapeutic Potential
Vascular Disease Prevention (Discontinued) The Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2
Cardiovascular & Hematological Disorders-Drug Targets Insulin- and Growth Factor-Resistance Impairs Vascular Regeneration in Diabetes Mellitus
Current Vascular Pharmacology Centralized and Local Color Doppler Ultrasound Reading Agreement for Diagnosis of the Chronic Cerebrospinal Venous Insufficiency in Patients with Multiple Sclerosis
Current Neurovascular Research